前列地尔治疗急性缺血性肠病的疗效观察  

Observation of the curative effect of alprostadil in the treatment of acute ischemic bowel disease

作　　者：黄仕尧[1] 姚凡保[1] 谢春松[1] 

机构地区：[1]广东医学院附属三水医院消化内科,广东佛山528100

出　　处：《吉林医学》2015年第14期3000-3002,共3页Jilin Medical Journal

摘　　要：目的:观察前列地尔治疗急性缺血性肠病的临床疗效。方法:选取80例缺血性肠病患者,随机方法分组。对照组患者接受常规综合治疗,试验组患者在此基础上接受前列地尔治疗。对比分析两组患者临床疗效和不良反应的差异性。结果:经过治疗后试验组总有效率明显高于对照组,经卡方检验分析发现组间差异有统计学意义(P<0.05)。两组治疗期间不良反应发生率经χ2检验分析发现无统计学意义(P>0.05)。结论:采用前列地尔辅助治疗急性缺血性肠病,可有效提高治疗效果,且不会增加不良反应,值得临床推广应用。Objective To observe the clinical effect of alprostadil in the treatment of acute ischemie bowel disease. Method 80 cases of ischemic bowel disease patients were analyzed,they were randomly divided into control group and experimental group. The control group re- ceived routine comprehensive treatment, the experimental group accepted alprostadil treatment on the basis of routine complehensive treat- ment. Compared the difference of the two groups in clinical efficacy and adverse reactions. Results After treatment, the clinical efficacy in the experimental group was better than that in the control group,there was signifieant difference between the two groups （P 〈 0. 05）. During the two groups the incidence of adverse reaction there was no statistical significance （ P 〉 0. 05 ）. Conclusion Alprostadil in treatment of patients with acute isehemic bowel disease, can effectively improve the treatment effect,without increasing adverse reactions,it is worthy of clinical ap-plication.

关 键 词：前列地尔 急性缺血性肠病 临床疗效 

分 类 号：R574[医药卫生—消化系统]